Research focuses on cellular and molecular mechanisms of neurodegeneration, identifying novel druggable targets, discovering prodromal biomarkers and novel reengineered gut microbiome based therapeutics for treatment of neurological disorders such as Parkinson’s and Alzheimer’s diseases and related dementia.